RESUMEN
We examined surgically excised pterygial tissues from 26 patients for the various immunoglobulin classes by direct immunofluorescence. Of the 26 patients, 19 (73.1%) showed positive staining with goat anti-human IgG fluorescein-labeled antibody. Direct immunofluorescence with goat anti-human IgE fluorescein-labeled antibody was found in all 26 samples, varying in fluorescent intensity from 1+ to 4+. Routine histologic staining disclosed an infiltration of small lymphocytes and plasma cells into the pterygium. These results suggest that an immunologic mechanism, possibly Type 1 hypersensitivity, may contribute to the pathogenesis of pterygium.
Asunto(s)
Hipersensibilidad , Pterigion/inmunología , Polvo , Técnica del Anticuerpo Fluorescente , Humanos , Inmunoglobulina E/análisis , Inmunoglobulina G/análisis , Irritantes , Linfocitos , Células Plasmáticas , Factor de Crecimiento Derivado de Plaquetas/fisiología , Polen/inmunología , Pterigion/patología , Pterigion/fisiopatologíaRESUMEN
The results of a study of 975 pterygia treated surgically and immediately with Strontium 90 are presented. The recurrence rate (quiescent) was 6%. The actual recurrence requiring surgery was 0.82%. Technique of removal involves simple wide excision and immediate treatment with Strontium 90 over the entire area. Three thousand RADS is the maximum dosage. In most instances more than 3000 RADS is cataractogenic. Two methods of Strontium 90 production are discussed. Strontium 90 has a half life of 19.9 plus or minus .3 years. It decomposes to Yttrium 90 which has a half life of 62 hours. Tissue penetration is estimated by the use of polystyrene absorber which is considered to be a tissue equivalent. Age and sex occurrence is given from a survey of 832 patients. Newer developments that might replace Strontium 90 are briefly discussed.
